Literature DB >> 4091025

A study of the septum pellucidum and corpus callosum in schizophrenia with MR imaging.

R J Mathew, C L Partain, R Prakash, M V Kulkarni, T P Logan, W H Wilson.   

Abstract

Surface areas of the septum pellucidum, corpus callosum and the brain were measured from mid-saggital slices obtained with magnetic resonance imaging in 18 patients with schizophrenia and an equal number of normal volunteers. The patients showed larger septa and septo-brain ratios. These indices correlated with age in both patients and controls. In the patients, septal area also correlated with duration of illness. Changes in the septum pellucidum were unrelated to the intensity of positive and negative symptoms of schizophrenia. The patients had significantly longer corpora callosa, but the two groups did not differ on its size or the ratio between the latter and the mid-saggital slice area. Dimensions of the corpus callosum did not correlate with age, duration of the illness or positive and negative symptoms of schizophrenia. The anteroposterior elongation of the structure seemed to accompany enlargement of the septum pellucidum.

Entities:  

Mesh:

Year:  1985        PMID: 4091025     DOI: 10.1111/j.1600-0447.1985.tb02634.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  11 in total

Review 1.  Subdomains within the negative symptoms of schizophrenia: commentary.

Authors:  Brian Kirkpatrick; Bernard Fischer
Journal:  Schizophr Bull       Date:  2006-02-21       Impact factor: 9.306

2.  Corpus callosal area differences and gender dimorphism in neuroleptic-naïve, recent-onset schizophrenia and healthy control subjects.

Authors:  John P John; Mohammed Kalathil Shakeel; Sanjeev Jain
Journal:  Schizophr Res       Date:  2008-06-26       Impact factor: 4.939

3.  Increased head circumference in schizophrenia.

Authors:  A S Bassett; E W Chow; A Bury; F Ali; C A Haylock; G N Smith; J S Lapointe; W G Honer
Journal:  Biol Psychiatry       Date:  1996-12-01       Impact factor: 13.382

4.  Volumetric analysis of septal region in schizophrenia and affective disorder.

Authors:  Ralf Brisch; Hans-Gert Bernstein; Dieter Krell; Renate Stauch; Kurt Trübner; Henrik Dobrowolny; Siegfried Kropf; Hendrik Bielau; Bernhard Bogerts
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-12-16       Impact factor: 5.270

5.  Cerebral atrophy and white matter disruption in chronic schizophrenia.

Authors:  Nicola Andreone; Michele Tansella; Roberto Cerini; Gianluca Rambaldelli; Amelia Versace; Giovanna Marrella; Cinzia Perlini; Nicola Dusi; Luisa Pelizza; Matteo Balestrieri; Corrado Barbui; Michela Nosè; Anna Gasparini; Paolo Brambilla
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-02       Impact factor: 5.270

6.  MRI study of cavum septi pellucidi in schizophrenia, affective disorder, and schizotypal personality disorder.

Authors:  J S Kwon; M E Shenton; Y Hirayasu; D F Salisbury; I A Fischer; C C Dickey; D Yurgelun-Todd; M Tohen; R Kikinis; F A Jolesz; R W McCarley
Journal:  Am J Psychiatry       Date:  1998-04       Impact factor: 18.112

Review 7.  Comorbid mood, psychosis, and marijuana abuse disorders: a theoretical review.

Authors:  Natascha Wilson; Jean Lud Cadet
Journal:  J Addict Dis       Date:  2009-10

8.  Cavum septum pellucidum in schizophrenia: clinical and neuropsychological correlates.

Authors:  Laura A Flashman; Robert M Roth; Heather S Pixley; Howard B Cleavinger; Thomas W McAllister; Robert Vidaver; Andrew J Saykin
Journal:  Psychiatry Res       Date:  2007-02-07       Impact factor: 3.222

9.  Morphometry of the corpus callosum in monozygotic twins discordant for schizophrenia: a magnetic resonance imaging study.

Authors:  M F Casanova; R D Sanders; T E Goldberg; L B Bigelow; G Christison; E F Torrey; D R Weinberger
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-05       Impact factor: 10.154

10.  Meta-analysis of corpus callosum size in schizophrenia.

Authors:  P W Woodruff; I C McManus; A S David
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-04       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.